New frontiers in the biosynthesis of psychoactive specialized metabolites
Current Opinion in Plant Biology September 16, 2024 Ginny Li, Peter J. Facchini 6 citations
The recent relaxation of psychedelic drug regulations has prompted extensive clinical investigation into their potential use to treat diverse mental health conditions including anxiety, depression, post-traumatic stress, and substance-abuse disorders. Most clinical trials have relied on a small number of known molecules found in nature, such as psilocybin, or long-known synthetic analogs of...